The anti-oxidant, anti-inflammatory, and anti-vaso-occlusive protections afforded by Hp/Hpx in SS-mice provide a rational basis for supplementation in Hp/Hpx-depleted SCD patients. This evidence concerns the gene HPX and Schnyder corneal dystrophy.